Skip to main content Back to Top
Advertisement

1/13/2025

Amino Acid Products

Products Affected - Description

    • Aminosyn II (sulfite-free) injection, ICU Medical, 10%, 2000 mL flexible container, 6 count, NDC 00990-7172-17
    • Aminosyn II (sulfite-free) injection, ICU Medical, 15%, 2000 mL flexible container, 6 count, NDC 00990-7171-17
    • Aminosyn-PF (sulfite-free) injection, ICU Medical, 10%, 1000 mL flexible container, 6 count, NDC 00990-4179-05
    • Aminosyn-PF (sulfite-free) injection, ICU Medical, 7%, 500 mL flexible container, 12 count, NDC 00990-4178-03
    • Clinisol (sulfite-free) injection, Baxter, 15%, 2000 mL flexible container, 6 count, NDC 00338-0502-06
    • Clinisol (sulfite-free) injection, Baxter, 15%, 500 mL flexible container, 24 count, NDC 00338-0502-03
    • Premasol (sulfite-free) injection, Baxter, 10%, 1000 mL flexible container, 12 count, NDC 00338-1130-04
    • Premasol (sulfite-free) injection, Baxter, 10%, 2000 mL flexible container, 6 count, NDC 00338-1130-06
    • Premasol (sulfite-free) injection, Baxter, 10%, 500 mL flexible container, 24 count, NDC 00338-1130-03
    • Prosol (sulfite-free) injection, Baxter, 20%, 2000 mL flexible container, 6 count, NDC 00338-0499-06
    • Travasol injection, Baxter, 10%, 1000 mL flexible container, 12 count, NDC 00338-0644-04
    • Travasol injection, Baxter, 10%, 2000 mL flexible container, NDC 00338-0644-06
    • Travasol injection, Baxter, 10%, 500 mL flexible container, 6 count, NDC 00338-0644-03

Reason for the Shortage

    • Baxter has all amino acid presentations on allocation due to increased demand.
    • BBraun has Plenamine and TrophAmine available. The company has discontinued FreAmine III and ProcalAmine.
    • ICU Medical has Aminosyn on shortage due to manufacturing delays and shortage of an active ingredient.

Available Products

    • Plenamine injection, BBraun, 15%, 1000 mL flexible container, 8 count, NDC 00264-4500-00
    • Plenamine injection, BBraun, 15%, 2000 mL flexible container, 8 count, NDC 00264-4500-05
    • TrophAmine injection, BBraun, 10%, 500 mL plastic container, 12 count, NDC 00264-1933-10

Estimated Resupply Dates

    • Baxter has all amino acid presentations on allocation.
    • ICU Medical has Aminosyn II 10% 2,000 mL, 15% 2,000 mL flexible containers, 7% Aminosyn-PF in 500 mL, and 10% Aminosyn-PF in 1,000 mL containers are on back order and the company cannot estimate a release date.

Implications for Patient Care

Safety

    • ASPEN provides recommendations for managing shortages of parenteral nutrition products. See their website for more details.

Updated

Updated January 13, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 21, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT